Antiviral response and resistance surveillance for HBeAg
positive patients enrolled in a combination study evaluationg
emtricitabine plus clevudine versus emtricitabine monotherapy
for the treatment of chronic hepatitis B infection.

J 2005

Antiviral response and resistance surveillance for HBeAg positive patients enrolled in a combination study evaluationg emtricitabine plus clevudine versus emtricitabine monotherapy for the treatment of chronic hepatitis B infection.

SNOW, Andi; Zahary KRASTEV; Seng Gee LIM; Tay Meng NG; Iskreen Andreev KOTZEV et al.

Základní údaje

Originální název

Antiviral response and resistance surveillance for HBeAg positive patients enrolled in a combination study evaluationg emtricitabine plus clevudine versus emtricitabine monotherapy for the treatment of chronic hepatitis B infection.

Název česky

Protivirová odpověď a rezistence u HBeAg pozitivních pacientů zařazených do kombinační studie hodnotící emtricitabin a clevudin versus mononoterapii emtricitabinem u chronické hepatitidy B.

Autoři

Vydání

Hepatology, Philadelphia, W.B.Saunders Company, 2005, 0270-9139

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30300 3.3 Health sciences

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 9.792

Označené pro přenos do RIV

Organizační jednotka

Lékařská fakulta

UT WoS

000232480302062

Změněno: 21. 11. 2005 13:22, prof. MUDr. Petr Husa, CSc.

Citovat

SNOW, Andi; Zahary KRASTEV; Seng Gee LIM; Tay Meng NG; Iskreen Andreev KOTZEV; Sing CHAN; Petr HUSA; Jan ŠPERL; Herve MOMMJA-MARIN; Katyna BORROTO-ESODA; Cary MOXHAM; Jane ANDERSON; Elsa MONDOU; Jeff SORBEL a Franck ROUSSEAU. Antiviral response and resistance surveillance for HBeAg positive patients enrolled in a combination study evaluationg emtricitabine plus clevudine versus emtricitabine monotherapy for the treatment of chronic hepatitis B infection. Hepatology. Philadelphia: W.B.Saunders Company, 2005, roč. 42, Suppl. 1, s. 1004A, 1 s. ISSN 0270-9139.

@article{589102,
   author = {Snow, Andi and Krastev, Zahary and Lim, Seng Gee and Ng, Tay Meng and Kotzev, Iskreen Andreev and Chan, Sing and Husa, Petr and Šperl, Jan and MommjaandMarin, Herve and BorrotoandEsoda, Katyna and Moxham, Cary and Anderson, Jane and Mondou, Elsa and Sorbel, Jeff and Rousseau, Franck},
   article_location = {Philadelphia},
   article_number = {Suppl. 1},
   language = {eng},
   issn = {0270-9139},
   journal = {Hepatology},
   title = {Antiviral response and resistance surveillance for HBeAg positive patients enrolled in a combination study evaluationg emtricitabine plus clevudine versus emtricitabine monotherapy for the treatment of chronic hepatitis B infection.},
   volume = {42},
   year = {2005}
}

TY  - JOUR
ID  - 589102
AU  - Snow, Andi - Krastev, Zahary - Lim, Seng Gee - Ng, Tay Meng - Kotzev, Iskreen Andreev - Chan, Sing - Husa, Petr - Šperl, Jan - Mommja-Marin, Herve - Borroto-Esoda, Katyna - Moxham, Cary - Anderson, Jane - Mondou, Elsa - Sorbel, Jeff - Rousseau, Franck
PY  - 2005
TI  - Antiviral response and resistance surveillance for HBeAg positive patients enrolled in a combination study evaluationg emtricitabine plus clevudine versus emtricitabine monotherapy for the treatment of chronic hepatitis B infection.
JF  - Hepatology
VL  - 42
IS  - Suppl. 1
SP  - 1004A
EP  - 1004A
PB  - W.B.Saunders Company
SN  - 02709139
ER  -

SNOW, Andi; Zahary KRASTEV; Seng Gee LIM; Tay Meng NG; Iskreen Andreev KOTZEV; Sing CHAN; Petr HUSA; Jan ŠPERL; Herve MOMMJA-MARIN; Katyna BORROTO-ESODA; Cary MOXHAM; Jane ANDERSON; Elsa MONDOU; Jeff SORBEL a Franck ROUSSEAU. Antiviral response and resistance surveillance for HBeAg positive patients enrolled in a combination study evaluationg emtricitabine plus clevudine versus emtricitabine monotherapy for the treatment of chronic hepatitis B infection. \textit{Hepatology}. Philadelphia: W.B.Saunders Company, 2005, roč.~42, Suppl. 1, s.~1004A, 1 s. ISSN~0270-9139.

Přehled o publikaci